News

Dr Stein currently serves on the president’s board of advisors for science and innovation for the University of California and is scientific advisor to Takeda San Diego. David

Dr Philip succeeds Richard Sessions, Znomics co-founder and interim CEO, who will remain as a consultant to the company and as an active member of Znomics’s board of

The agreement includes $257 million in potential payments to GTC for meeting clinical, regulatory, and sales milestones, including a $3 million payment from Ovation to GTC at the

Ranexa is approved for use in Europe as an add-on therapy for the symptomatic treatment of patients with stable angina pectoris who are inadequately controlled or intolerant to

Dr Parry-Billings joined Topigen in 2007 as chief development officer and expanded his role to lead the company’s operations in early 2008. Previously, Dr Parry-Billings was European director

Inovio and International AIDS Vaccine Initiative (IAVI) signed an initial agreement in March 2007. The parties have now extended this agreement by three years. As part of this

By combining ClinPhone with Perceptive Informatics, Parexel’s wholly-owned technology subsidiary, Perceptive is now said to be one of the industry’s largest eClinical technology providers. The combined company is

Heilongjiang Tianlong Pharmaceutical, a wholly-owned subsidiary of China Sky One Medical has recently completed R&D for the spray, which includes the active ingredients naphazoline hydrochloride chlorpheniramine maleate and

The one-year agreement is subject to an extension under certain terms and conditions and does not include a trademark license. As part of the agreement, Dusa will receive